Featuring: publicly traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX & OTC: BB) and Canadian (TSX & TSX-V) stock exchanges, Investment & Money Management Ideas. |
|
|
Press Release - Provectus Pharmaceuticals, Inc. (PVCT-OCT: BB) |
|
|
We have solved the essential problem that other scientists and companies have not been able to solve; that is to make a cancer specific drug. We have found out how to make it simply, pragmatically and inexpensively; namely, to build it and make a very safe molecule. - Dr. H. Craig Dees, Ph.D. (PVCT) (Interview published April 12, 2007) |
The Most Powerful Name In Corporate News and Information. |
|
CURRENT ISSUE | COVER ARCHIVES | INDEX | CONTACT | FINANCIALS | MARKETING SERVICES | HOME PAGE |
|
Provectus News Video of Dr.
Agarwala's June 7 Presentation On PV-10 For Melanoma Available
In a presentation given Monday June 7, 2010, Dr. Sanjiv Agarwala, the Principal Investigator for the Phase 2 clinical trial of PV-10 for metastatic melanoma conducted at St. Luke's Hospital & Health Network, expands on the clinical data that was presented in the poster session at ASCO 2010. A video of Dr. Agarwala's presentation is available on the Provectus website at http://www.pvct.com/ASCO2010.html.
|
|
